DRW Securities’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,800
Closed -$230K 1583
2025
Q4
$230K Buy
+7,800
New +$212K 0.01% 860
2024
Q1
Sell
-3,800
Closed -$378K 448
2023
Q4
$378K Buy
+3,800
New +$320K 0.01% 210
2021
Q1
Sell
-2,600
Closed -$272K 212
2020
Q4
$272K Buy
+2,600
New +$263K 0.01% 101

Other funds holding MRNA

DRW Securities's MRNA Position: Q1 2026 in Review

DRW Securities sold out of Moderna (MRNA) in Q1 2026, closing a stake of 8,442 shares — an estimated $249K sold.

DRW Securities first reported a position in MRNA in Q4 2020 and held it in 5 quarters. The position peaked at $276K in Q4 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • DRW Securities reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 8,442 Moderna shares in Q1 2026, an estimated $249K.
  • DRW Securities first reported a position in Moderna in Q4 2020 and held it in 5 quarters.
  • DRW Securities's Moderna position peaked at $276K in Q4 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.